The economic impact of compassionate use of medicines

– Research
– Open Access
– [Published:] The economic impact of compassionate use of medicines
1303
Compassionate use programs (CUP) for medicines respond to the ethical imperative of providing access to medicines before marketing approval to patients not recruited in trials. The economic impact of clinical trials has previously been investigated. No evidence on the net economic benefit of CUP exists.

Read the source article at BMC Health Services Research
2021-12-04 00:00:00